Guillain-Barré Syndrome is NOT a Myopathy—It is a Polyradiculoneuropathy
GBS does not have associations with other causes of myopathy because it fundamentally affects peripheral nerves and nerve roots, not muscle tissue itself. This is a critical diagnostic distinction that prevents misdiagnosis and inappropriate treatment 1.
Understanding the Pathophysiology
GBS is an immune-mediated disease of the peripheral nerves and nerve roots—specifically a polyradiculoneuropathy, not a myopathy 1. The disease process involves:
- Aberrant immune response targeting peripheral nerve components (gangliosides, myelin, or axons)
- Complement activation and macrophage infiltration of nerves
- Damage to the peripheral nervous system, NOT primary muscle pathology 1
The weakness in GBS results from denervation (loss of nerve supply to muscles), not from intrinsic muscle disease.
Critical Differential Diagnosis Considerations
You must actively rule out true myopathies when evaluating suspected GBS 1, 2. The differential diagnosis includes:
- Acute benign infectious myositis (viral myositis with elevated CK)
- Critical illness myopathy/polyneuropathy in ICU settings 3
- Toxic myopathies from drugs or chemical substances 2
- Neuromyopathy of the intensive care unit patient 2
Key Distinguishing Features:
For GBS:
- Areflexia or hyporeflexia (reflexes decreased/absent) 1
- Ascending pattern of weakness
- Electrophysiology shows peripheral nerve dysfunction (demyelination or axonopathy) 1
- CSF shows albuminocytologic dissociation (elevated protein, normal cell count) 1
For True Myopathy:
- Reflexes typically preserved until late disease
- Proximal > distal weakness pattern
- Elevated creatine kinase (CK) levels
- EMG shows myopathic changes (not neuropathic)
- Muscle biopsy shows primary muscle pathology
Rare Exception: Polymyositis Association
One extremely rare case report documents concurrent GBS and polymyositis 4. This 2022 case described a young woman with:
- Ascending paralysis and respiratory failure (GBS features)
- Persistent proximal muscular disability despite plasmapheresis
- Biological myolysis (elevated muscle enzymes)
- EMG and muscle biopsy confirming polymyositis
This represents a syndromic association of two separate autoimmune diseases, not a causal relationship 4. The authors emphasize this has been reported only once in medical literature, making it an exceptional curiosity rather than a clinically relevant association.
Clinical Pitfalls to Avoid
- Do not attribute weakness in GBS to myopathy—the muscle weakness is secondary to denervation, not primary muscle disease
- If CK is significantly elevated or reflexes are preserved, reconsider the diagnosis and investigate for true myopathy
- In ICU patients with weakness, distinguish between GBS (which may lead to ICU admission) and critical illness polyneuropathy/myopathy (which develops after ICU admission) 3
- Electrophysiology is essential—it differentiates neuropathic from myopathic processes 1, 2
Bottom Line
GBS has no meaningful clinical associations with other causes of myopathy. The two conditions represent fundamentally different disease processes affecting different anatomical structures. Any apparent overlap represents either diagnostic confusion or the exceptionally rare coincidence of two separate autoimmune diseases occurring simultaneously 4.